Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 4,500 shares changing hands.
Resverlogix Stock Performance
The company has a current ratio of 0.03, a quick ratio of 0.04 and a debt-to-equity ratio of -83.11. The company’s 50-day moving average price is C$0.10 and its two-hundred day moving average price is C$0.10. The company has a market cap of C$30.11 million, a P/E ratio of -3.17 and a beta of 0.72.
Resverlogix (TSE:RVX – Get Free Report) last announced its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 EPS for the quarter. As a group, equities analysts forecast that Resverlogix Corp. will post -0.22 earnings per share for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
